HealthEquity Net Worth 2014-2024 | HQY
Interactive chart of historical net worth (market cap) for HealthEquity (HQY) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. HealthEquity net worth as of April 23, 2024 is $6.97B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $6.966B | $1.000B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $123.697B | 15.52 |
| Cencora (COR) | United States | $47.247B | 18.86 |
| ICON (ICLR) | Ireland | $24.578B | 24.24 |
| DiDi Global (DIDIY) | China | $22.930B | 0.00 |
| Avantor (AVTR) | United States | $16.557B | 22.81 |
| CochLear (CHEOY) | $13.675B | 0.00 | |
| Viatris (VTRS) | United States | $13.496B | 3.85 |
| Revvity (RVTY) | United States | $12.448B | 21.67 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.029B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.979B | 21.84 |
| Medpace Holdings (MEDP) | United States | $11.658B | 38.35 |
| Solventum (SOLV) | United States | $10.708B | 0.00 |
| Natera (NTRA) | United States | $10.700B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| Bausch + Lomb (BLCO) | Canada | $5.145B | 19.78 |
| Doximity (DOCS) | United States | $4.625B | 34.43 |
| Organon (OGN) | United States | $4.601B | 4.46 |
| PACS (PACS) | United States | $3.460B | 0.00 |
| Progyny (PGNY) | United States | $3.177B | 53.32 |
| Sotera Health (SHC) | United States | $3.139B | 15.40 |
| Surgery Partners (SGRY) | United States | $3.044B | 28.28 |
| Life Times (LTH) | United States | $2.774B | 30.65 |
| GoodRx Holdings (GDRX) | United States | $2.631B | 133.20 |
| Premier (PINC) | United States | $2.522B | 9.23 |
| Teladoc Health (TDOC) | United States | $2.252B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.141B | 6.93 |
| Agilon Health (AGL) | United States | $2.121B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.816B | 0.00 |
| Agiliti (AGTI) | United States | $1.368B | 22.33 |
| Establishment Labs Holdings (ESTA) | $1.325B | 0.00 | |
| NovoCure (NVCR) | Jersey | $1.273B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.947B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.759B | 7.85 |
| Embecta (EMBC) | United States | $0.617B | 4.08 |
| InnovAge Holding (INNV) | United States | $0.548B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.518B | 0.00 |
| Enhabit (EHAB) | United States | $0.515B | 46.64 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 0.00 |
| CareDx (CDNA) | United States | $0.423B | 0.00 |
| LifeMD (LFMD) | United States | $0.404B | 0.00 |
| Beauty Health (SKIN) | United States | $0.404B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.395B | 0.00 |
| DocGo (DCGO) | United States | $0.366B | 58.50 |
| MultiPlan (MPLN) | United States | $0.356B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.317B | 0.00 |
| ModivCare (MODV) | United States | $0.312B | 4.14 |
| GeneDx Holdings (WGS) | United States | $0.271B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.260B | 0.00 |
| Sharecare (SHCR) | United States | $0.250B | 0.00 |
| So-Young (SY) | China | $0.131B | 44.00 |
| Biodesix (BDSX) | United States | $0.125B | 0.00 |
| Oncology Institute (TOI) | United States | $0.084B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.063B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| NeueHealth (NEUE) | United States | $0.052B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.034B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.024B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| OpGen (OPGN) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |